Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
1.4100 x 1 1.4800 x 4
Post-market by (Cboe BZX)
1.4600 +0.0700 (+5.04%) 04/22/25 [NASDAQ]
1.4100 x 1 1.4800 x 4
Post-market 1.4700 +0.0100 (+0.68%) 19:41 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.3800
Day High
1.4700
Open 1.4100
Previous Close 1.3900 1.3900
Volume 112,300 112,300
Avg Vol 270,550 270,550
Stochastic %K 77.50% 77.50%
Weighted Alpha -38.51 -38.51
5-Day Change +0.1500 (+11.45%) +0.1500 (+11.45%)
52-Week Range 1.1300 - 2.6600 1.1300 - 2.6600
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,039
  • Shares Outstanding, K 89,237
  • Annual Sales, $ 27,860 K
  • Annual Income, $ -14,230 K
  • EBIT $ -15 M
  • EBITDA $ -16 M
  • 60-Month Beta 3.19
  • Price/Sales 4.71
  • Price/Cash Flow N/A
  • Price/Book 2.39

Options Overview Details

View History
  • Implied Volatility 224.34% ( -142.47%)
  • Historical Volatility 64.51%
  • IV Percentile 92%
  • IV Rank 54.06%
  • IV High 366.81% on 04/21/25
  • IV Low 56.70% on 06/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 19
  • Volume Avg (30-Day) 49
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 7,360
  • Open Int (30-Day) 9,738

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.06
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1300 +29.20%
on 04/09/25
Period Open: 1.5700
1.6493 -11.48%
on 03/25/25
-0.1100 (-7.01%)
since 03/21/25
3-Month
1.1300 +29.20%
on 04/09/25
Period Open: 2.3800
2.6600 -45.11%
on 02/10/25
-0.9200 (-38.66%)
since 01/22/25
52-Week
1.1300 +29.20%
on 04/09/25
Period Open: 1.8900
2.6600 -45.11%
on 02/10/25
-0.4300 (-22.75%)
since 04/22/24

Most Recent Stories

More News
Compugen: Q4 Earnings Snapshot

Compugen: Q4 Earnings Snapshot

CGEN : 1.4600 (+5.04%)
3 Penny Stocks With 10% to 210% Upside Potential

Investors should consider these three penny stocks for their solid upside potential, even after this year's rally.

CGEN : 1.4600 (+5.04%)
MAPS : 1.0500 (+0.96%)
AZN : 67.87 (+1.45%)
$SPX : 5,287.76 (+2.51%)
GCG25 : 2,916.8s (+0.42%)
NGD : 3.47 (-5.71%)
GILD : 105.51 (+1.13%)
Compugen: Q3 Earnings Snapshot

Compugen: Q3 Earnings Snapshot

CGEN : 1.4600 (+5.04%)
Compugen: Q2 Earnings Snapshot

Compugen: Q2 Earnings Snapshot

CGEN : 1.4600 (+5.04%)
5 Growth Stocks Under $10 to Scoop Up Now

Investment in penny stocks can be a risky proposition. However, here are 5 stocks that could have major upside potential, according to Wall Street analysts.

CGEN : 1.4600 (+5.04%)
QCOM : 138.74 (+1.91%)
BITF : 0.9424 (+12.88%)
INDI : 1.8500 (+1.09%)
GSAT : 18.99 (-0.21%)
KOS : 1.7700 (-1.67%)
Compugen to Present at Single Cell Genomics 2023 Meeting

/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.4600 (+5.04%)
Compugen Expands Intellectual Property with New Japanese Patent for the Triple Combination of any Anti-PVRIG, TIGIT and PD-1 Antibody for the Treatment of Cancer

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.4600 (+5.04%)
Compugen to Present at the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.4600 (+5.04%)
Compugen Reports Second Quarter 2023 Results

Advancing enrollment in two proof-of-concept studies evaluating triple blockade of DNAM-1 axis in patients with microsatellite stable colorectal cancer and...

CGEN : 1.4600 (+5.04%)
Compugen to Release Second Quarter 2023 Results on Monday, August 7, 2023

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

CGEN : 1.4600 (+5.04%)

Business Summary

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas...

See More

Key Turning Points

3rd Resistance Point 1.5833
2nd Resistance Point 1.5267
1st Resistance Point 1.4933
Last Price 1.4600
1st Support Level 1.4033
2nd Support Level 1.3467
3rd Support Level 1.3133

See More

52-Week High 2.6600
Fibonacci 61.8% 2.0755
Fibonacci 50% 1.8950
Fibonacci 38.2% 1.7145
Last Price 1.4600
52-Week Low 1.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro